The Cell & Gene Therapy Forum will further enhance its status as the world’s premier event for the sector’s senior decision-makers; the world’s first and still largest event focused on defining the successful development and commercialization models for C> products. This January will see an expanded agenda exploring manufacturing, product characterization, logistics, R&D and regulatory challenges and solutions in detail, as well as the second renewal of the associated Stem Cells as Discovery Research Tools stream.

Neil Palmer (PDCI’s President and Principal Consultant) will be speaking and participating in a panel at the Cell & Gene Therapy Forum 2015.

HTA, Funding & Reimbursement of Cell & Gene Therapy – A Global Perspective

• Health technology assessment challenges in assessing clinical and cost effectiveness of cell / gene therapies
• Who pays?  Healthcare system determinants of funding / reimbursement paradigm
• Affordability – Pricing and budget impact challenges